tradingkey.logo
tradingkey.logo
Search

Transmedics Group Inc

TMDX
Add to Watchlist
87.000USD
-1.070-1.21%
Close 09-23 16:00ET
3.01BMarket Cap
17.24P/E TTM

About Transmedics Group Inc Company

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Transmedics Group Inc Profile

Ticker SymbolTMDX
Company nameTransmedics Group Inc
IPO dateMay 02, 2019
CEOHassanein (Waleed H)
Number of employees728
Security typeOrdinary Share
Fiscal year-endMay 02
Address200 Minuteman Road
CityANDOVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01810
Phone19785520900
Websitehttps://www.transmedics.com/
Ticker SymbolTMDX
IPO dateMay 02, 2019
CEOHassanein (Waleed H)

Company Executives of Transmedics Group Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
614.00K
+8.09%
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
614.00K
+8.09%
Mr. James R. (Jim) Tobin
Mr. James R. (Jim) Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. James R. (Jim) Tobin
Mr. James R. (Jim) Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
26.07K
+44.98%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
26.07K
+44.98%
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
20.24K
+85.20%
Mr. Giovanni Cecere
Mr. Giovanni Cecere
Chief Commercial Officer
Chief Commercial Officer
19.06K
+58.15%
Mr. Giovanni Cecere
Mr. Giovanni Cecere
Chief Commercial Officer
Chief Commercial Officer
19.06K
+58.15%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
16.64K
+58.05%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
614.00K
+8.09%
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
614.00K
+8.09%
Mr. James R. (Jim) Tobin
Mr. James R. (Jim) Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. James R. (Jim) Tobin
Mr. James R. (Jim) Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
26.07K
+44.98%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
26.07K
+44.98%

FAQs

Who are the top five shareholders of Transmedics Group Inc?

The top five shareholders of Transmedics Group Inc are: Dr. Waleed H. Hassanein, M.D.

How many institutions hold shares of Transmedics Group Inc (TMDX)?

As of 2026Q1, 865 institutions hold shares of Transmedics Group Inc, with a combined market value of approximately 42.29M, accounting for 122.36% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -1737478.00.

What is the biggest source of revenue for Transmedics Group Inc?

In 2026Q1, the OCS Liver net revenue business generated the highest revenue for Transmedics Group Inc, amounting to 148.23M and accounting for 78.49% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.